Code | 6809D | ||||||||||
MA number | EU/1/20/1513/002 | ||||||||||
Product Form: | sol inj 2x0,4 ml/40 mg (striek.inj.napl.skl.) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | Celltrion Healthcare Hungary Kft., Hungary | ||||||||||
Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Route of admin.: | Subcutaneous use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 10(4) similar biological application |
MA issued: | 11.02.2021 |
Validity: | 11.02.2026 |
SmPC + PL: |
|
Safety feature | Yes |
Data update: | 11.03.2022 |